Search
for
Sort by
Research 211–240 of 356
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- Mechanistic study of decreased skin penetration using a combination of sonophoresis with sodium fluorescein-loaded PEGylated liposomes with D-limonene
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Clinical Characteristics and Factors Associated with Hair Loss Severity in Chronic Hepatitis B Patients Receiving Pegylated Interferon-Alpha: A Retrospective Cohort Study
- Microneedle‐Assisted Delivery of PEGylated Recombinant Human Fusion Collagen for Androgenetic Alopecia: Preclinical and Pilot Clinical Evidence
- PEGylated Flavonoid Aspasomes as a Brain-Targeted Nano-Vesicular Platform for Enhanced Neuroprotection in Stress-Induced Cognitive Dysfunction
- PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo
- Case report: temporal hollowness augmentation with PEGylated fillers
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- 만성 B형 간염 환자에서 Pegylated 인터페론 알파2a 치료 중 발생한 원형 탈모
- Development of PEGylated Liposomes
- A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer
- Structure-guided PEGylated fibroblast growth factor 2 variants accelerate wound healing with improved stability
- Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma
- Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon α 2a therapy for chronic hepatitis C virus infection
- Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
- Hyperammonemia with Valproic Acid: Colonic Ischemia Associated with “Triptan” Use Visual Side Effects with Pegylated Interferon: Alopecia Areata with Infliximab: Adverse Effects Seen with Medications Used for Irritable Bowel Syndrome
- Targeted gene delivery to skin cells in vivo: A comparative study of liposomes and polymers as delivery vehicles
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy
- Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria
- Cutaneous necrosis after injection of polyethylene glycol–modified interferon alfa
- Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C.
- Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN ?-2a /Ribavirin Combination Therapy
- Robust Metformin Nanosystem Promotes Hair Growth in Androgenetic Alopecia
- Widespread and eruptive comedonal lesions with alopecia
- Psoriasis and Hepatitis C: Improvement with Interferon
- Hop Shoots (<i>Humulus lupulus</i>): Emerging Bioactive Components, Functional Properties, and Opportunities for Food and Bio-Industrial Applications
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Cover stories: 10 start-ups to watch: Liquid Light
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection